Thrombopoietin, Soluble CD40 Ligand, and Platelet Count During Veno-arterial Extracorporeal Membrane Oxygenation

Volume: 68, Issue: 5, Pages: e77 - e79
Published: May 29, 2021
Abstract
Thrombocytopenia is common during extracorporeal membrane oxygenation (ECMO), and severe thrombocytopenia occurs in up to 25% of patients.1 A recent systematic review and meta-analysis confirmed that around a quarter of adult ECMO patients develop thrombocytopenia and up to half of patients require platelet transfusion.2 The authors concluded that the mechanisms causing thrombocytopenia are multifactorial and remain poorly understood.2...
Paper Details
Title
Thrombopoietin, Soluble CD40 Ligand, and Platelet Count During Veno-arterial Extracorporeal Membrane Oxygenation
Published Date
May 29, 2021
Volume
68
Issue
5
Pages
e77 - e79
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.